Key result
Acute atherosis was associated with a more than six-fold increased risk of placental lesions consistent with maternal vascular underperfusion (aOR 6.7; 95% CI 5.2-8.6).
Why the study?
Is acute atherosis associated with specific placental lesions in pregnant women?
Cohort (n=14,786)
No
Is acute atherosis associated with specific placental lesions in pregnant women?
Effect estimate: aOR 6.7 (95% CI 5.2-8.6)
Acute atherosis in pregnant women is strongly associated with placental lesions indicative of maternal vascular underperfusion, fetal vascular thrombo-occlusive disease, and chronic chorioamnionitis.
Acute atherosis may warrant enhanced placental assessment; leaves open causal links and clinical utility pending prospective studies.
OBJECTIVE: Acute atherosis is a lesion of the spiral arteries characterized by fibrinoid necrosis of the vessel wall, an accumulation of fat-containing macrophages, and a mononuclear perivascular infiltrate, which can be found in patients with preeclampsia, fetal death, small-for-gestational age, spontaneous preterm labor/premature prelabor rupture of membrane, and spontaneous mid-trimester abortion. This lesion is thought to decrease blood flow to the intervillous space which may lead to other vascular lesions of the placenta. The objective of this study was to test whether there is an association between acute atherosis and placental lesions that are consistent with maternal vascular underperfusion (MVU), amniotic fluid infection (AFI), fetal vascular thrombo-occlusive disease (FVTOD) or chronic inflammation. MATERIAL AND METHODS: A retrospective cohort study of pregnant women who delivered between July 1998 and July 2014 at Hutzel Women's Hospital/Detroit Medical Center was conducted examine 16 457 placentas. The frequency of placenta lesions (diagnosed using the criteria of the Perinatal Section of the Society for Pediatric Pathology) was compared between pregnancies with and without acute atherosis. RESULTS: Among 16 457 women who were enrolled, 10.2% (1671/16 457) were excluded, leaving 14 786 women who contributed data for analysis. Among them, the prevalence of acute atherosis was 2.2% (326/14 786). Women with acute atherosis were more than six times as likely as those without to have placental lesions consistent with maternal underperfusion (adjusted odds ratio - aOR: 6.7; 95% CI 5.2-8.6). To a lesser degree, acute atherosis was also associated with greater risks of having either lesions consistent with FVTOD (aOR 1.7; 95% CI 1.2-2.3) or chronic chorioamnionitis (aOR 1.9; 95% CI 1.3-3), but not with other chronic inflammatory lesions, after adjusting for gestational age at delivery. In contrast, women with acute atherosis were 60% less likely to have lesions consistent with AFI, adjusting for gestational age at delivery (aOR 0.4; 95% CI 0.3-0.5). CONCLUSIONS: Acute atherosis is associated with increased risks of having placental lesions consistent with MVU, and to a lesser extent, chronic chorioamnionitis and those consistent with FVTOD.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2014) conducted a cohort in Acute atherosis and placental lesions (n=14,786). Acute atherosis vs. Without acute atherosis was evaluated on Placental lesions consistent with maternal vascular underperfusion (MVU) (aOR 6.7, 95% CI 5.2-8.6). Acute atherosis was associated with a more than six-fold increased risk of placental lesions consistent with maternal vascular underperfusion (aOR 6.7; 95% CI 5.2-8.6).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: